Amit Janu

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 421 citations

Medicine, Oncology, Pharmacology +15

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Vijay Patil, Vanita Noronha, Nandini Menon et al. · Journal of Clinical Oncology · 2022 · 206 citations

Medicine, Oncology, Pharmacotherapy +7

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Vijay Patil, Vanita Noronha, Amit Joshi et al. · ESMO Open · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients

Archya Dasgupta, Tejpal Gupta, Sona Pungavkar et al. · Neuro-Oncology · 2018 · 68 citations · Full text

Medicine, Oncology, Radiology +17

&lt;em&gt;EGFR &lt;/em&gt;mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

Amit Joshi, Saurabh Zanwar, Vanita Noronha et al. · OncoTargets and Therapy · 2017 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17